ENPP2 and hepatocellular carcinoma: Further treating HCC cells with ATX inhibitor (GLPG1690) showed that restraining endogenous LPA production significantly reversed exogenous LPA-stimulated macropinocytosis of LG-EVs (Supplementary Fig. S4G-J).